It may mean: Focus on improving the efficiency in drug development read me Involving payers and patient groups in strategic planning Increasing presence in the emerging markets and addressing the needs of patients in these areas Innovations in reaching to the physicians and helping them in the capacity building of healthcare The pharmaceutical physician should take the lead in all these changes. In addition to this, the future role of pharmaceutical physicians would include: Health economics Currently, the role of pharmaceutical physicians in health economics, especially in India, is limited. There is an increased thought on the proactive role of the government in the supply of medicines in the public sector. In the long term, this could mean the requirement of India specific health economic studies.

It is also possible that payers ?? private as well as public will become more vocal in their role in the selection of medicines. We envision that major efforts will be required in organized financing of healthcare in the future ?? the selection of the model (public or private or both) can be finalized later. The pharmaceutical physician could play an important role, be it in the development of pricing models, negotiating with payers on the ??real value?? of medicines or capacity building. Policy shaping In India, there can be a gap between policy and implementation. This can be more acute in social sectors like health. Even as the government would continue to lead to shape the health policy, it would expect professionals, especially from the pharmaceutical industry, to help them draft these policies, provide expertise, and even assess the outcomes of their implementation.

The pharmaceutical physician is expected to be more acceptable to other clinician groups as well as the government. The pharmaceutical physician would have a major role in surveillance and epidemiology studies, in the outcome assessment of health policy, and in employing management techniques in the planning stage. Strategic Entinostat planning As the Indian industry has become global, there are avenues for collaboration between multinational companies, global Indian companies, and companies with a focus on biotechnology. The role of a medically qualified professional in the strategic planning of business and in looking for possible avenues for alliance and partnership is likely to become more pronounced. If there are not many innovative molecules in protein inhibitors the pipeline for interested therapy area, companies may like to invest in acquisitions (of companies/ products) and alliances with smaller companies. In such cases, the medical advisors have a chance to utilize their expertise for giving critical and valuable medical inputs, which would help in shaping the company’s future.